Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"TE7660XO1C"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Hanley%2C+Michael+J%22&type=Person&filter%5B%5D=topic_facet%3A%22TE7660XO1C%22
/vufind/Search/Results?lookfor=%22Hanley%2C+Michael+J%22&type=Person&filter%5B%5D=topic_facet%3A%22TE7660XO1C%22
Search /vufind/Search2/Results?lookfor=%22Hanley%2C+Michael+J%22&type=Person&filter%5B%5D=topic_facet%3A%22TE7660XO1C%22
PubPharm (13)
1
Population pharmacokinetic/pharmacodynamic joint modeling of ixazomib efficacy and safety using data from the pivotal phase III TOURMALINE-MM1 study in multiple myeloma patients
enthalten in:
CPT: pharmacometrics & systems pharmacology
| 2022
von
Srimani, J.
|
Diderichsen, P.
|
Hanley, M.
| +3
Wird geladen...
2
Clinical Pharmacology of Ixazomib : The First Oral Proteasome Inhibitor
enthalten in:
Clinical pharmacokinetics
| 2019
von
Gupta, N.
|
Hanley, M.
|
Xia, C.
| +3
Wird geladen...
3
Model-Informed Drug Development for Ixazomib, an Oral Proteasome Inhibitor
enthalten in:
Clinical pharmacology and therapeutics
| 2019
von
Gupta, N.
|
Hanley, M.
|
Diderichsen, P.
| +9
Wird geladen...
4
A phase I study to assess the mass balance, excretion, and pharmacokinetics of [14C]-ixazomib, an oral proteasome inhibitor, in patients with advanced solid tumors
enthalten in:
Investigational new drugs
| 2018
von
Gupta, N.
|
Zhang, S.
|
Pusalkar, S.
| +8
Wird geladen...
5
Effects of Strong CYP3A Inhibition and Induction on the Pharmacokinetics of Ixazomib, an Oral Proteasome Inhibitor : Results of Drug-Drug Interaction Studies in Patients With Advanced Solid Tumors or Lymphoma and a Physiologically Based Pharmacokinetic Analysis
enthalten in:
Journal of clinical pharmacology
| 2018
von
Gupta, N.
|
Hanley, M.
|
Venkatakrishnan, K.
| +13
Wird geladen...
6
A Phase 1 Study to Assess the Relative Bioavailability of Two Capsule Formulations of Ixazomib, an Oral Proteasome Inhibitor, in Patients With Advanced Solid Tumors or Lymphoma
enthalten in:
Journal of clinical pharmacology
| 2018
von
Hanley, M.
|
Gupta, N.
|
Venkatakrishnan, K.
| +6
Wird geladen...
7
Population Pharmacokinetic Analysis of Ixazomib, an Oral Proteasome Inhibitor, Including Data from the Phase III TOURMALINE-MM1 Study to Inform Labelling
enthalten in:
Clinical pharmacokinetics
| 2017
von
Gupta, N.
|
Diderichsen, P.
|
Hanley, M.
| +4
Wird geladen...
8
Dose and Schedule Selection of the Oral Proteasome Inhibitor Ixazomib in Relapsed/Refractory Multiple Myeloma : Clinical and Model-Based Analyses
enthalten in:
Targeted oncology
| 2017
von
Gupta, N.
|
Yang, H.
|
Hanley, M.
| +6
Wird geladen...
9
Randomized, double-blind, placebo-controlled phase III study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma : China Continuation study
enthalten in:
Journal of hematology & oncology
| 2017
von
Hou, J.
|
Jin, J.
|
Xu, Y.
| +18
Wird geladen...
10
The Effect of a High-Fat Meal on the Pharmacokinetics of Ixazomib, an Oral Proteasome Inhibitor, in Patients With Advanced Solid Tumors or Lymphoma
enthalten in:
Journal of clinical pharmacology
| 2016
von
Gupta, N.
|
Hanley, M.
|
Venkatakrishnan, K.
| +5
Wird geladen...
1
2
Nächster »
[2]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: TE7660XO1C
Medienart
13
Aufsätze
13
E-Artikel
13
E-Ressourcen
Zeitschriftentitel
3
Journal of clinical pharmacology
2
Clinical pharmacokinetics
2
Journal of hematology & oncology
1
British journal of clinical pharmacology
1
British journal of haematology
1
CPT: pharmacometrics & systems pharmacology
1
Clinical pharmacology and therapeutics
1
Investigational new drugs
1
Targeted oncology
Alle anzeigen ...
weniger ...
Thema
13
71050168A2
13
Boron Compounds
13
Glycine
13
Journal Article
TE7660XO1C
13
ixazomib
9
Proteasome Inhibitors
9
Research Support, Non-U.S. Gov't
8
Clinical Trial, Phase I
5
Antineoplastic Agents
5
Randomized Controlled Trial
4
multiple myeloma
4
pharmacokinetics
2
4Z8R6ORS6L
2
7S5I7G3JQL
2
Clinical Trial, Phase III
2
Dexamethasone
2
F0P408N6V4
2
Ixazomib
2
Lenalidomide
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
1
2020-
12
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
13
Englisch
Haven't found what you're looking for?
Wird geladen...